Cord Blood Adipocyte Fatty Acid-Binding Protein Levels Correlate With Gestational Age and Birth Weight in Neonates.
Infants born small for gestational age (SGA) have increased risk for obesity and metabolic syndrome, but the underlying mechanisms are not fully elucidated. Adipocyte fatty acid-binding protein (AFABP) is an adipokine that has been implicated in modulation of insulin sensitivity and lipid metabolism. Higher plasma AFABP levels are associated with increased risk of metabolic syndrome and cardiovascular morbidity in adults. Alterations in AFABP levels during fetal growth have not been characterized.



To examine AFABP levels in neonatal cord blood in relation to gestational age and birth weight.



A cross-sectional study of 361 neonates born at a tertiary academic center.



Plasma AFABP levels were measured by enzyme-linked immunosorbent assay. For comparison, venous samples from 26 adults were analyzed.



AFABP levels were higher in neonates compared with adults (P < 0.01). Preterm infants had higher AFABP levels [48.2 (31.2 to 73.3) ng/mL] compared with full-term infants [35.8 (25.1 to 51.5)] ng/mL, P < 0.01). There was a negative correlation between AFABP and gestational age (r = 0.28, P = 0.02). Among full-term infants, AFABP levels in SGA infants were lower [28.6 (24.2 to 37.3) ng/mL], compared with appropriate for gestational age [36.1 (25.5 to 50.4) ng/mL] and large for gestational age infants [45.0 (24.6 to 62.4) ng/mL, P < 0.05].



These associations may reflect the higher metabolic activity during fetal development. AFABP may also be involved in fetal growth and the association between SGA status and obesity and metabolic syndrome in later life.
Department of Pediatric Newborn Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.|Harvard Medical School, Boston, Massachusetts 02115.
Kyoung Eun
KE
Joung
Department of Pediatric Newborn Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.|Harvard Medical School, Boston, Massachusetts 02115.
Sule Umit
SU
Cataltepe
Department of Pediatric Newborn Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.|Harvard Medical School, Boston, Massachusetts 02115.
Zoe
Z
Michael
Department of Pediatric Newborn Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.|Harvard Medical School, Boston, Massachusetts 02115.|Division of Newborn Medicine, Boston Children's Hospital, Boston, Massachusetts 02115.
Helen
H
Christou
Harvard Medical School, Boston, Massachusetts 02115.|Division of Endocrinology and Metabolism, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215.|Section of Endocrinology, Boston VA Healthcare System, Division of Endocrinology, Jamaica Plain, Massachusetts 02130.
Christos S
CS
Mantzoros
D000328:Adult; D001724:Birth Weight; D003430:Cross-Sectional Studies; D004797:Enzyme-Linked Immunosorbent Assay; D050556:Fatty Acid-Binding Proteins / Q000097:blood*; D005260:Female; D005312:Fetal Blood; D005320:Fetal Macrosomia / Q000097:blood*; D005865:Gestational Age; D006801:Humans; D062071:Infant, Extremely Premature / Q000097:blood; D007231:Infant, Newborn; D007234:Infant, Premature / Q000097:blood*; D007236:Infant, Small for Gestational Age / Q000097:blood*; D008297:Male
C493410:FABP4 protein, human; D050556:Fatty Acid-Binding Proteins